SERI Lugano: ParaCel Riboflavin Selected by FDA for Epi-on Cross-Linking for Keratoconus2019-03-212019-03-21http://www.seri-lugano.ch/wp-content/uploads/2019/03/seri-lugano-roberto-pinelli-3.pngSERI Luganohttps://www.seri-lugano.ch/wp-content/uploads/2019/03/roberto-pinelli-paracel-seri-lugano.png200px200px
